Biological activity and structure–activity relationship of dehydrodieugenol B analogues against visceral leishmaniasis

Biological activity and structure–activity relationship of dehydrodieugenol B analogues against visceral leishmaniasis

Visceral leishmaniasis is a neglected protozoan disease with high mortality. Existing treatments exhibit a number of limitations, resulting in a significant challenge for public health, especially in developing countries in which the disease is endemic. With a limited pipeline of potential drugs in...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Amaral, M, Asiki, H, Sear, CE, Singh, S, Pieper, P, Haugland, MM, Anderson, EA, Tempone, AG
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Royal Society of Chemistry 2023

Míreanna comhchosúla

Synthesis and structure–activity relationship of dehydrodieugenol B neolignans against Trypanosoma cruzi
de réir: Sear, CE, et al.
Foilsithe / Cruthaithe: (2020)

Synthesis and anti-parasitic activity of dehydrodieugenol B and analogues
de réir: Sear, C
Foilsithe / Cruthaithe: (2020)

Dehydrodieugenol B derivatives as antiparasitic agents: synthesis and biological activity against Trypanosoma cruzi
de réir: Ferreira, D, et al.
Foilsithe / Cruthaithe: (2019)

Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India.
de réir: Michaela Fakiola, et al.
Foilsithe / Cruthaithe: (2019-08-01)

Mediastinal Lymphadenopathy in Visceral Leishmaniasis
de réir: Surinder Singh Rana, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Evaluating the Antischistosomal Activity of Dehydrodieugenol B and Its Methyl Ether Isolated from Nectandra leucanthaA Preclinical Study against Schistosoma mansoni Infection
de réir: Vinicius C. Rocha, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis.
de réir: Ambak K Rai, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis.
de réir: Amanda C Stanley, et al.
Foilsithe / Cruthaithe: (2008-02-01)

Immunity to Visceral Leishmaniasis
de réir: Nahid Ali, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Treatment of visceral leishmaniasis
de réir: Sinasi Ozsoylu
Foilsithe / Cruthaithe: (2003-07-01)

Epidemiology of visceral leishmaniasis
de réir: Ready PD
Foilsithe / Cruthaithe: (2014-05-01)

Treatment of visceral leishmaniasis
de réir: E M Moore, et al.
Foilsithe / Cruthaithe: (2010-01-01)

Congenital Visceral Leishmaniasis
de réir: Catharina C. Boehme, et al.
Foilsithe / Cruthaithe: (2006-02-01)

Immunobiology of visceral leishmaniasis
de réir: Susanne eNylén, et al.
Foilsithe / Cruthaithe: (2012-08-01)

Impact of ASHA training on active case detection of visceral leishmaniasis in Bihar, India.
de réir: Vidya Nand Ravi Das, et al.
Foilsithe / Cruthaithe: (2014-05-01)

Synthesis and evaluation of (bis)benzyltetrahydroisoquinoline alkaloids as antiparasitic agents
de réir: Sozanschi, A, et al.
Foilsithe / Cruthaithe: (2024)

Visceral Leishmaniasis in Rural Bihar, India
de réir: Epco Hasker, et al.
Foilsithe / Cruthaithe: (2012-10-01)

Apigenin is a promising molecule for treatment of visceral leishmaniasis
de réir: Yago S. S. Emiliano, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
de réir: Ganesh Yadagiri, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Immunoactivation and immunopathogeny during active visceral leishmaniasis Imunoativação e imunopatogenia durante leishmaniose visceral ativa
de réir: Hiro Goto, et al.
Foilsithe / Cruthaithe: (2009-10-01)

Correction: Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection
Foilsithe / Cruthaithe: (2013-01-01)

Correction: Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection.
de réir: Yegnasew Takele, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Re-emergence of visceral leishmaniasis in Gujarat, India
de réir: Umakant Sharma, Naresh Singh Redhu, Purva Mathur , Sarman Singh
Foilsithe / Cruthaithe: (2007-09-01)

Genetics, Transcriptomics and Meta-Taxonomics in Visceral Leishmaniasis
de réir: Jenefer M. Blackwell, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Structure-activity relationship study of cytotoxic neolignan derivatives using multivariate analysis and computation-aided drug design.
de réir: de Sousa, FS, et al.
Foilsithe / Cruthaithe: (2020)

Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
de réir: Om Prakash Singh, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Relationship of serum antileishmanial antibody with development of visceral leishmaniasis, post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse
de réir: Mondal, D, et al.
Foilsithe / Cruthaithe: (2019)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
de réir: Dinesh Mondal, et al.
Foilsithe / Cruthaithe: (2019-10-01)

Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis
de réir: Maiara Maria Romanelli, et al.
Foilsithe / Cruthaithe: (2019-10-01)

Visceral leishmaniasis and leishmaniasis-HIV coinfection: comparative study
de réir: João Victor Soares Coriolano Coutinho, et al.

Visceral leishmaniasis in AIDS patient
de réir: E. L. Nicodemo, et al.
Foilsithe / Cruthaithe: (1990-08-01)

Urban Visceral Leishmaniasis in Venezuela
de réir: CM Aguilar, et al.
Foilsithe / Cruthaithe: (1998-01-01)

The kinetoplast in the diagnosis of visceral leishmaniasis
de réir: Henry W. Murray
Foilsithe / Cruthaithe: (2022-01-01)

Visceral Leishmaniasis Treatment, Italy
de réir: Luigi Gradoni, et al.
Foilsithe / Cruthaithe: (2003-12-01)

Splenic aspiration in visceral leishmaniasis
de réir: P.A. Kager
Foilsithe / Cruthaithe: (1992-12-01)

Glomerulopathy Associated with Visceral leishmaniasis
de réir: Sh Khademvatan, et al.
Foilsithe / Cruthaithe: (2007-03-01)

Epidemiology of visceral leishmaniasis in Georgia.
de réir: Giorgi Babuadze, et al.
Foilsithe / Cruthaithe: (2014-03-01)

RECALLING IMMUNE RESPONSES POST VISCERAL LEISHMANIASIS
de réir: B. Singh, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Sporadic case of visceral leishmaniasis in Sikkim, India
de réir: Luna Adhikari, et al.
Foilsithe / Cruthaithe: (2010-01-01)

Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis
de réir: Jéssica Adriana de Jesus, et al.
Foilsithe / Cruthaithe: (2021-01-01)